Lifeboat Foundation

It’s happening…

MOSCOW — KFC has partnered with a Russian bioprinting company to bring 3D printed chicken nuggets to the table.

Coined as the “meat of the future,” the lab-created chicken meat is KFC’s response to the growing interest of healthy lifestyles, the rise in demand for meat alternatives and the increasing need to develop more environmentally friendly methods of food production.

Continue reading “‘Meat of the future’: KFC to ‘3D bioprint’ meat using ‘animal flesh cells’” »

“The partners are working together to develop the world’s first laboratory-produced chicken nuggets. The 3D printed nuggets are expected to be similar in taste and appearance to KFC’s original product, but will have the benefit of being more environmentally friendly to produce.”

When I think of KFC and its largely unchanging menu of fried chicken, I do not immediately think of innovation. However a new collaboration forged between the fast-food company and Russia-based bioprinting firm 3D Bioprinting Solutions might just change my mind. The partners are working together to develop the world’s first laboratory-produced chicken nuggets. The 3D printed nuggets are expected to be similar in taste and appearance to KFC’s original product, but will have the benefit of being more environmentally friendly to produce.

The bioprinted chicken nugget project is already underway, and the unlikely partners plan to have a final product ready for testing by this fall. The effort is part of KFC’s mission to create a “restaurant of the future” which leverages state-of-the-art technologies like 3D bioprinting to overcome solutions in the food industry today: such as finding more eco-friendly alternatives to traditional meat.

Continue reading “Printer lickin‘ good: KFC is bioprinting chicken nuggets” »

Their new approach to 3D bioprinting and allows for non-invasive tissue growth and wound healing. It works through injecting bioink cells, the additive material traditionally used in 3D bioprinting, under the skin and using near-infrared light to penetrate the tissue and transfer customizable building designs — like an ear or an abstract shape — to newly injected cells.

The ear began to form in just 20 seconds.

Using a new approach to 3D bioprinting researchers have designed a way to non-invasively grow a wide range of customizable tissue under living skin.

The future of bioprinting looks promising from a technical and scientific perspective, but it’s far from clear how it will be regulated.

A burn that is over 25% of the human body area can be life threatening. However a burn that is only 1 percent but on a visible area of the body can be life-worsening. That is why advancements in the area of wound care and burns treatment are so important from patient perspective. Being a doctor of the future will include having a point-of-care device such as a 3D-Bioprinter that will scan the lesions in dept and width and print a gel imbued with cells and prolo-factors.

Forgive me my conservatism… we already have such clinics that are on the clinical trials for such treatments.

Read more in the article. Stay tuned for more topics through the Academy blog. Gain more knowledge in Regenerative Medicine and practical experience with biologics through the Annual Congress — Global Regenerative Congress 18–20 September 2020 in Dubai. Registrations are open: www.grc2020dubai.com

Continue reading “Handheld bioprinter for treating burns at the point-of-care” »

3D bio-printed Lung tissue.

Rice University researcher’s bioprinting method could be scaled up to one day construct an entire organ and allow organs to be made using some of a patient’s own cells to prevent organ rejection. Researcher’s long term goals are to bioprint fully functioning organs. Synthetic organs can extend the waiting period of an average 3.6 years for a real organ.

Continue reading “3D Bioprinted Organ Just Took Its First ‘Breath’” »

ROCK HILL, South Carolina and REHOVOT, Israel , January 13, 2020 – Today, 3D Systems (NYSE: DDD) and CollPlant Biotechnologies (NASDAQ: CLGN), announced signing a joint development agreement intended to play a pivotal role in advancing and accelerating breakthroughs in the biomedical industry. The collaboration brings together two industry pioneers—3D Systems, renowned for its 3D printing technologies and healthcare expertise; and CollPlant, the developer of proprietary recombinant human collagen (rhCollagen) BioInk technology currently used for 3D bioprinting of tissues and organs. The two companies plan to jointly develop tissue and scaffold bioprinting processes for third party collaborators.

You might call it a giant leap for 3D bioprinting: Human heart cells have been 3D printed on the International Space Station (ISS) and are making their way back to Earth this week inside a SpaceX capsule. The 3D BioFabrication Facility (BFF) was developed by Techshot Inc., a commercial operator of microgravity research and manufacturing equipment, in partnership with nScrypt, a manufacturer of industrial 3D bioprinters and electronics printers.

“Our BFF has the potential to transform human healthcare in ways not previously possible,” said Techshot President and CEO John Vellinger.” We’re laying the foundation for an entire industry in space.”

If you’re wondering why they don’t just print the cells here on Earth, the answer is gravity. When attempting to print with soft, easily flowing biomaterials on Earth, the tissues collapse under their own weight, resulting in little more than a puddle, explained Techshot in a press release. “But when these same materials are used in the microgravity environment of space, the 3D-printed structures maintain their shapes.” The bio-ink used in the space station, consequently, did not contain the scaffolding materials or thickening agents normally required to resist the Earth’s gravitational pull.